Janus Henderson Group plc 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:58 pm Sale | 2024-12-31 | 13G | Akero Therapeutics, Inc. AKRO | JANUS HENDERSON GROUP PLC JHG | 6,034,239 8.700% | -1,043,239 (-14.74%) | Filing |
| 2024-11-14 3:59 pm Purchase | 2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO | JANUS HENDERSON GROUP PLC JHG | 7,077,478 10.200% | 127,060 (+1.83%) | Filing |
| 2024-06-10 4:17 pm Purchase | 2024-05-31 | 13G | Akero Therapeutics, Inc. AKRO | JANUS HENDERSON GROUP PLC JHG | 6,950,418 10.100% | 2,644,017 (+61.40%) | Filing |
| 2024-02-13 11:31 am Purchase | 2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO | JANUS HENDERSON GROUP PLC JHG | 4,306,401 7.700% | 966,227 (+28.93%) | Filing |
| 2023-02-10 11:27 am Purchase | 2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO | JANUS HENDERSON GROUP PLC JHG | 3,340,174 7.100% | 176,552 (+5.58%) | Filing |
| 2022-02-10 2:07 pm Sale | 2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO | JANUS HENDERSON GROUP PLC JHG | 3,163,622 9.100% | -329,797 (-9.44%) | Filing |
| 2021-02-11 3:50 pm Sale | 2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO | JANUS HENDERSON GROUP PLC JHG | 3,493,419 10.100% | -13,809 (-0.39%) | Filing |
| 2020-09-10 2:14 pm Purchase | 2020-08-31 | 13G | Akero Therapeutics, Inc. AKRO | JANUS HENDERSON GROUP PLC JHG | 3,507,228 10.100% | 1,097,695 (+45.56%) | Filing |